RPL36A and lung carcinoma: Expression analysis revealed significant differences and upregulation of RPL36A in various tumours, including breast cancer, renal clear cell carcinoma, hepatocellular carcinoma, pancreatic cancer and lung cancer, compared to normal tissues.